申请人:AstraZeneca AB
公开号:EP1987831A1
公开(公告)日:2008-11-05
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes.
The invention also relates to a novel group of compounds of Formula (I) and to methods for preparing compounds of Formula (I).
本发明涉及式(I)化合物或其盐、溶液或原药(其中 R1、R2、R3、n 和 m 如说明书所述)在制备治疗或预防通过葡萄糖激酶(GLK)介导的疾病(如 2 型糖尿病)的药物中的用途。
本发明还涉及一组新型的式(I)化合物和制备式(I)化合物的方法。